May 07, 2019
Actinium Announces Appointment of Niva Almaula, Ph.D. as Chief Business Officer
May 01, 2019
Blue Sky Uranium Announces Corporate Update
Apr 16, 2019
QUIKRETE® Rehabs Aging Transportation Infrastructure with Proven Bridge Repair Materials
Apr 16, 2019
Department of Commerce Submits Uranium Section 232 Report to President Trump
Apr 08, 2019
Actinium's Leading Clinical, Preclinical, Production and IP Efforts Related to Actinium-225 Highlighted at Preeminent Targeted Alpha Therapy International Symposium
Mar 29, 2019
Actinium Successfully Completes Second Module of Collaborative Research Program with Astellas; Third Module Initiated
Mar 26, 2019
Actinium Highlights its Participation at the Upcoming Targeted Alpha Therapy International Symposium with Presentations on its AWE Platform, Clinical Programs and New Source of Ac-225 Isotope
Mar 19, 2019
Actinium Appoints Accomplished FDA and Industry Professional Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs
Mar 15, 2019
Actinium Provides Comprehensive Patent Portfolio Update Including New IP Filings
Mar 07, 2019
Westwater Announces Royalty and Promissory Note Sale for $2.75 Million
Feb 26, 2019
Middleby Schedules Fourth Quarter Earnings Release and Conference Call
Feb 21, 2019
Reprocessing Uranium Is No Problem for Penetron Technology
Feb 05, 2019
Actinium Initiates Novel Phase 1/2 Combination Trial of Actimab-A and Venetoclax
Jan 23, 2019
Actinium Pharmaceuticals Appoints Accomplished Industry Executive Cynthia Pussinen as Executive Vice President of Technical Operations and Supply Chain
Jan 16, 2019
Actinium Pharmaceuticals Appoints Qing Liang, PhD, DABR as Vice President, Head of Radiation Sciences to Further Innovation for its AWE Technology Platform and Growing Pipeline of Antibody Radiation Conjugate Therapies
Jan 14, 2019
Ur-Energy Provides 2018 Q4 Operational Results
Jan 08, 2019
Why Are We Still Drinking That Radioactive Water?
Dec 03, 2018
Actinium Highlights Actimab-A Phase 2 Trial Results in Older Patients with Unfit AML from ASH Annual Meeting Demonstrating Single Agent Activity of the CD33 Antibody Radiation Conjugate
Nov 27, 2018
Ur-Energy and Energy Fuels Host U.S. Department of Commerce Section 232 Investigators on Tour of Domestic Uranium Mines and Mills
Nov 19, 2018
Actinium Pharmaceuticals, Inc. to Present at 30th Annual Piper Jaffray Healthcare Conference